Main | Insilico Medicine
Product of Interest
- PandaOmics
- PandaOmics Box
- Chemistry42
- Generative Biologics
- Science42: DORA
- inClinico
Pharma.ai Webinar 2026 Q2 Summer Updates
Register for On-Demand Access!
Chemistry42
Indication
- Phase III
- Phase II
- Phase I
- IND-enabling
- Lead opt.
- Hit-to-lead
- Target ID
Available for licensing
Generative AI Software for Drug Discovery, Scientific Research & Sustainability
High Quality Therapeutic Programs Discovered Using Generative AI and Automation
Medicine42
Science42
Large Language of Life Models (LLLMs)
Publications
Notable Publications
- PhotoAgeClock: deep learning algorithms for development of non-invasive visual biomarkers of aging
- Target identification and assessment in the era of AI
- LongevityBench: Are SotA LLMs ready for aging research?
Generative AI and Automation for Longevity and Sustainability
Our mission is to extend healthy productive longevity for everyone by transforming drug discovery and development with generative artificial intelligence, significantly reducing the time and cost to bring life-saving medications to patients.